Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

TrackMagicFormul (79.03) Submitted: 5/15/2013 6:56:28 AM : Start Price: $3.10 ENZN Score: +0.40

Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.

Jun 13 $2.50 strike at $0.10 has 23% discount and 39% annualized return.

jschinagle (< 20) Submitted: 5/13/2013 4:26:19 PM : Start Price: $3.08 ENZN Score: -1.60

nothing left after large liquidating dividend

Hotpicks101 (29.72) Submitted: 1/21/2011 6:11:35 PM : Start Price: $8.24 ENZN Score: -90.51

Klarman. Cheap.

jsgant13 (99.09) Submitted: 9/13/2010 1:01:00 PM : Start Price: $7.80 ENZN Score: -106.66

baupost, deej and value

NoIcons (< 20) Submitted: 2/28/2010 6:33:42 PM : Start Price: $6.69 ENZN Score: -101.41

outperform

TMFBreakerJava (99.36) Submitted: 11/19/2009 12:34:32 AM : Start Price: $7.69 ENZN Score: -108.51

This biotech has a reliable royalty revenue stream from its proprietary pegylation technology which makes drugs less toxic, and more effective. It has a solid balance sheet and some interesting compounds in the pipeline. It has just sold off a portfolio of drugs to fix the balance sheet. Undervalued due to years of questionable decisions by management, the new CEO has now put the house in order, which promises appreciation to fair value and more gains if one of the drugs in the pipeline pans out.

healthcare1 (< 20) Submitted: 1/17/2009 5:04:27 AM : Start Price: $4.44 ENZN Score: -128.51

it has a unique drug delivery system and activist shareholders

mjan706 (67.14) Submitted: 9/22/2008 1:44:10 AM : Start Price: $5.62 ENZN Score: -79.89

An Icahn portfolio stock.

hennessy7 (54.25) Submitted: 5/26/2008 9:12:50 AM : Start Price: $6.30 ENZN Score: -74.27

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

WonderWolf (86.43) Submitted: 5/20/2008 11:48:35 PM : Start Price: $6.32 ENZN Score: -70.92

Working on 2 cancer drugs and will be the big winner!!

Addgirl48 (47.72) Submitted: 3/29/2008 11:21:19 AM : Start Price: $6.61 ENZN Score: -82.76

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

djinsanity (< 20) Submitted: 2/9/2008 12:17:36 PM : Start Price: $5.80 ENZN Score: -74.93

PEG-SN38 showed anti-tumor activity in resistant pre-clinical models, FDA approval for DepoCyt, leader in stem cell research, I can see it doing phenomenal

henncoop (87.65) Submitted: 3/7/2007 11:04:59 AM : Start Price: $5.88 ENZN Score: -71.88

low PE &amp; a good choice for a play in this sector

pbqstraining (< 20) Submitted: 1/12/2007 10:52:34 PM : Start Price: $6.10 ENZN Score: -70.81

NICE PIPELINE

j3nzsrfs (< 20) Submitted: 11/25/2006 10:29:17 PM : Start Price: $5.95 ENZN Score: -72.01

New cancer treatment